Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02689284 |
|---|---|
| Brief Title: | Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer |
| First Submitted : | January 27, 2016 |
| First Submitted that Met QC Criteria : | February 18, 2016 |
| First Posted : | February 23, 2016 (Estimate) |
| Results First Submitted : | February 28, 2022 |
| Results First Submitted that Met QC Criteria : | July 11, 2022 |
| Results First Posted : | August 4, 2022 |
| Last Update Submitted that Met QC Criteria : | July 11, 2022 |
| Last Update Posted : | August 4, 2022 |